BIS

ProShares UltraShort Nasdaq Biotechnology

1 year -47.0%

Assets$2.00MProShares

Fee0.96%a year

Yield5.7%NA

This year-34.2%

5 years-18.5%a year on average

Components104top 10: 48%

Returns

This year -34.2% 1 year -47.0% 3 years, yearly -32.8% 5 years, yearly -18.5% 10 years, yearly -26.2%

The fund's own total return. Volatility 31.8% over one year, 32.2% over three; Sharpe ratio over three years -1.25.

Sectors

Not given for this fund.

Regions

Not given for this fund.

Asset classes

Cash191.3%

Other100.0%

Stock non-US-208.6%

About the fund

Issuer: ProShares
Since: 2010-04-06
Listed on: NASDAQ
ISIN: US74347G8380
Turnover: 0% a year

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

From the market data provider's fund data, read 2026-10-19. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.